Prim Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Los beneficios de Prim han disminuido a una tasa media anual de -2%, mientras que en la industria Medical Equipment los beneficios disminuyeron en un 5.9% anualmente. Los ingresos han ido creciendo a una tasa media de 9.9% al año. La rentabilidad financiera de Prim es de 10.1%, y sus márgenes netos son de 5.9%.

Información clave

-2.0%

Tasa de crecimiento de los beneficios

-1.5%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	-9.5%
Tasa de crecimiento de los ingresos	9.9%
Rentabilidad financiera	10.1%
Margen neto	5.9%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Prim. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

LSE:0FP0 Ingresos, gastos y beneficios (EUR Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	217	13	80
30 Sep 23	212	11	80
30 Jun 23	207	10	79
31 Mar 23	202	9	77
31 Dec 22	197	8	74
30 Sep 22	192	11	75
30 Jun 22	186	14	75
31 Mar 22	181	15	67
31 Dec 21	169	17	58
30 Sep 21	168	15	65
30 Jun 21	161	14	54
31 Mar 21	146	10	36
31 Dec 20	147	7	54
30 Sep 20	147	11	57
30 Jun 20	143	9	57
31 Mar 20	154	11	36
31 Dec 19	151	11	57
30 Sep 19	146	12	55
30 Jun 19	142	13	54
31 Mar 19	137	14	53
31 Dec 18	134	14	52
30 Sep 18	132	14	49
30 Jun 18	128	14	48
31 Mar 18	124	15	48
31 Dec 17	121	14	47
30 Sep 17	117	14	47
30 Jun 17	116	14	46
31 Mar 17	114	13	45
31 Dec 16	110	13	44
30 Sep 16	107	11	41
30 Jun 16	106	11	41
31 Mar 16	102	11	40
31 Dec 15	99	11	40
30 Sep 15	99	11	39
30 Jun 15	97	11	39
31 Mar 15	95	10	27
31 Dec 14	94	10	40
30 Sep 14	90	9	38
30 Jun 14	89	9	38
31 Mar 14	88	10	38
31 Dec 13	87	8	37
30 Sep 13	87	8	37
30 Jun 13	84	7	37

Ingresos de calidad: 0FP0 tiene un alto nivel de ganancias no monetarias.

Margen de beneficios creciente: Los actuales márgenes de beneficio (5.9%) de 0FP0 son superiores a los del año pasado (4.3%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de 0FP0 han disminuido en un 2% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de 0FP0 en el último año (51%) supera su media de 5 años (-2% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de 0FP0 en el último año (51%) superó al de la industria Medical Equipment 17.9%.

Prim Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Recent updates

Less than half of directors are independent

New major risk - Earnings quality

Less than half of directors are independent

Dividend of €0.089 announced

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

New minor risk - Earnings quality

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Upcoming dividend of €0.089 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Desglose de ingresos y gastos
Beta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Prim Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Recent updates

Less than half of directors are independent

New major risk - Earnings quality

Less than half of directors are independent

Dividend of €0.089 announced

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

New minor risk - Earnings quality

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Upcoming dividend of €0.089 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Desglose de ingresos y gastosBeta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Desglose de ingresos y gastos
Beta